Andale , Khurt Rendelle .

HRN: 25-13-12  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/25/2024
CEFTRIAXONE 1G (VIAL)
12/25/2024
01/01/2025
IV
1.3gms
OD
PCAP D
Waiting Final Action 

Indication:  ProphylaxisEmpiric    Type of Infection:  PneumoniaBloodstreamProphylaxis    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: